Samrat Pharmachem informs about issuance of duplicate certificate

30 Jan 2023 Evaluate
Samrat Pharmachem has informed that it enclosed the intimation letter dated January 30, 2023, received from its Registrar and Share Transfer Agent, Link Intime India, providing information regarding issue of duplicate share certificates to the shareholder(s) of the Company. The information is being submitted pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Samrat Pharmachem Share Price

479.90 3.50 (0.73%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.